New York-based healthcare communications company Klara announced it has secured funding from Stage 2 Capital — which is a venture capital firm that is backed by go-to-market professionals from leading technology companies that invests in early stage B2B software companies.
Stage 2 Capital was co-founded by Jay Po (former Bessemer Venture Partners investor) and Mark Roberge (former HubSpot CRO and author of The Sales Acceleration Formula). Former Marketo Chief Growth Officer Jill Rowley also joined as a partner several months ago.
“We decided to take Stage 2 Capital on board to actively support us in our go-to-market efforts, and we’re already seeing the impact,” said Klara co-founder and co-CEO Simon Bolz — who launched the company with co-founder and co-CEO Simon Lorenz, PhD in 2013.
Last year, Klara raised Series A funding from FirstMark Capital, Lerer Hippeau, Project A Ventures, Atlantic Labs, and investors Zac Weinberg and Nat Turner (Flatiron Health founders), Vivek Garipalli (Clover Health founder), and Clark Valberg (InVision founder).
The Klara platform offers the ability to connect patients with care teams. Through the platform, users can send messages, lab results, and photos. This data can be exported to EHRs. This ensures that patients are referred to the right professional.
“Klara stood out with its strong leadership team, and its distinct chance to not only become a billion dollar business in one of the most exciting categories of software, but also to revolutionize the healthcare system and significantly improve the patient experience,” added Po.
And Roberge explained that the teams worked closely together around a future growth path. Now they long-term work relationship has been developed and they are “set up for repeatable scale and healthy growth.”
